Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
NCT04172220Completed
Randomised, open-label trial (2 arms), sponsored by Centro di Riferimento Oncologico di Aviano. Primary endpoint: 24h Neutrophil to Lymphocyte Ratio variation. Started Oct 2019; status: completed.
Beyond the preview
Study design, results and competitive context are available in the Gosset platform where reported.
Available in the Gosset platform where reported.
Available in the Gosset platform where reported.
See how Gosset can support your research on NCT04172220.